William Blair Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-980,662
| Closed | -$241M | – | 418 |
|
|
2022
Q3 | $241M | Buy |
980,662
+2,504
| +0.3% | +$676K | 0.95% | 19 |
|
|
2022
Q2 | $242M | Buy |
978,158
+64,350
| +7% | +$17.4M | 0.9% | 20 |
|
|
2022
Q1 | $303M | Sell |
913,808
-110,140
| -11% | -$33.9M | 0.9% | 21 |
|
|
2021
Q4 | $368M | Buy |
1,023,948
+61,601
| +6% | +$20.8M | 0.99% | 13 |
|
|
2021
Q3 | $313M | Buy |
962,347
+29,774
| +3% | +$10.1M | 0.88% | 26 |
|
|
2021
Q2 | $291M | Sell |
932,573
-4,583
| -0.5% | -$1.41M | 0.91% | 31 |
|
|
2021
Q1 | $299M | Buy |
937,156
+370,442
| +65% | +$119M | 0.97% | 20 |
|
|
2020
Q4 | $184M | Sell |
566,714
-1,496
| -0.3% | -$414K | 0.61% | 62 |
|
|
2020
Q3 | $157M | Sell |
568,210
-7,932
| -1% | -$2.29M | 0.61% | 62 |
|
|
2020
Q2 | $139M | Buy |
576,142
+205,340
| +55% | +$41.2M | 0.57% | 70 |
|
|
2020
Q1 | $53.8M | Sell |
370,802
-274,035
| -42% | -$45.5M | 0.26% | 110 |
|
|
2019
Q4 | $110M | Sell |
644,837
-103,970
| -14% | -$19.3M | 0.44% | 76 |
|
|
2019
Q3 | $133M | Sell |
748,807
-66,717
| -8% | -$14.4M | 0.57% | 57 |
|
|
2019
Q2 | $212M | Buy |
815,524
+629,455
| +338% | +$167M | 0.89% | 25 |
|
|
2019
Q1 | $53.1M | Buy |
186,069
+58,242
| +46% | +$19.4M | 0.22% | 110 |
|
|
2018
Q4 | $41.5M | Sell |
127,827
-139,450
| -52% | -$48.4M | 0.21% | 118 |
|
|
2018
Q3 | $120M | Sell |
267,277
-16,097
| -6% | -$6.35M | 0.42% | 81 |
|
|
2018
Q2 | $116M | Sell |
283,374
-425,957
| -60% | -$154M | 0.43% | 69 |
|
|
2018
Q1 | $206M | Sell |
709,331
-253,536
| -26% | -$64.3M | 0.79% | 31 |
|
|
2017
Q4 | $180M | Buy |
962,867
+18,006
| +2% | +$3.36M | 0.7% | 34 |
|
|
2017
Q3 | $159M | Sell |
944,861
-28,933
| -3% | -$4.38M | 0.57% | 50 |
|
|
2017
Q2 | $140M | Sell |
973,794
-147,223
| -13% | -$19.8M | 0.51% | 61 |
|
|
2017
Q1 | $140M | Buy |
1,121,017
+91,651
| +9% | +$10.6M | 0.53% | 58 |
|
|
2016
Q4 | $116M | Buy |
1,029,366
+272,428
| +36% | +$31.6M | 0.46% | 74 |
|
|
2016
Q3 | $97.3M | Sell |
756,938
-56,433
| -7% | -$6.76M | 0.37% | 85 |
|
|
2016
Q2 | $88.9M | Buy |
813,371
+415
| +0.1% | +$41.3K | 0.35% | 94 |
|
|
2016
Q1 | $77.1M | Buy |
812,956
+3,524
| +0.4% | +$297K | 0.31% | 108 |
|
|
2015
Q4 | $73.1M | Buy |
809,432
+151,090
| +23% | +$12.8M | 0.3% | 113 |
|
|
2015
Q3 | $61.1M | Buy |
+658,342
| New | +$58M | 0.12% | 256 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
William Blair Investment Management's ABMD Position: Q4 2022 in Review
William Blair Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 980,662 shares — an estimated $241M sold.
William Blair Investment Management first reported a position in ABMD in Q3 2015 and held it in 29 quarters. The position peaked at $368M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- William Blair Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- William Blair Investment Management sold 980,662 Abiomed Inc shares in Q4 2022, an estimated $241M.
- William Blair Investment Management first reported a position in Abiomed Inc in Q3 2015 and held it in 29 quarters.
- William Blair Investment Management's Abiomed Inc position peaked at $368M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on William Blair Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.